Effects of CPAP treatment on pain in people with sleep apnea
Clinical Outcomes of Continuous Positive Airway Pressure Treatment in People With Obstructive Sleep Apnea
This study is testing if using a CPAP machine for sleep apnea can help reduce pain in people who also have chronic pain.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vrije Universiteit Brussel Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06834724 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between continuous positive airway pressure (CPAP) treatment and pain outcomes in individuals diagnosed with obstructive sleep apnea (OSA) and chronic pain. Participants will complete questionnaires at baseline, 3 months, and 6 months after starting CPAP therapy to assess pain intensity and CPAP adherence. The study aims to explore how CPAP usage and baseline apnea-hypopnea index (AHI) correlate with pain outcomes, as well as the prevalence of chronic pain in patients with OSA. The findings could provide insights into the management of chronic pain in patients undergoing CPAP treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been newly diagnosed with clinically relevant obstructive sleep apnea and are starting CPAP treatment.
Not a fit: Patients who are currently receiving CPAP treatment or have had CPAP treatment in the past year may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve pain management strategies for patients with both obstructive sleep apnea and chronic pain.
How similar studies have performed: While studies on the relationship between sleep and pain exist, this specific investigation into CPAP treatment's effects on chronic pain in OSA patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be 18 years of age or older * Participants must be able to read and write in Dutch, French or English * Participants must be diagnosed with clinically relevant OSA and newly start CPAP treatment: * AHI ≥ 15 * Prescribed CPAP for the first time as a treatment for their OSA * Participants must have read and signed the ICF Exclusion Criteria: * Participants who are currently receiving CPAP treatment or have had a CPAP treatment in the last year * Participant receiving CPAP for other conditions than OSA (e.g. Central Sleep Apnoea)
Where this trial is running
Brussels
- Universitair Ziekenhuis Brussel — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: Nils Runge, MSc
- Email: nils.arno.andreas.runge@vub.be
- Phone: +32 2 477 44 20
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.